European regulators have given Shockwave Medical CE mark approval for its Coronary Lithoplasty system for use in combination with stenting to treat coronary artery disease patients with calcified plaque. The system allows integration of angioplasty balloon catheter devices with lithotripsy, which creates calcium-disrupting sonic pressure waves.
EU OKs Shockwave Medical's Coronary Lithoplasty System
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.